Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Guy Gadois who wrote (1262)	1/27/1999 10:15:00 PM
From: MJ	Read Replies (2) \| Respond to of 1510

jon salmon This ia a truly intuitive first impression. It would appear positive to me given the relationship between AGPH and IMNR. Warner Lambert has the experience in producing and marketing. If there developes a firm tie with IMNR and IMNR is successful with any of the trials and gets approval for a drug that heals, then it would seem positive. There also was a previous response on this thread by someone posing the question about the possibility that Warner is interested in IMNR in addition to AGPH? Thinking about this, it could be that Warner would assume IMNR or that Warner would be a major financial backer for research for IMNR or produce the drugs as mentioned above. This is what I call brainstorming. Don't have a firm opinion---just thinking. What do you think? Negative? Or, Positive? mj